期刊文献+

含左氧氟沙星的三联疗法及序贯疗法与传统序贯疗法治疗幽门螺杆菌的疗效比较 被引量:8

A comparison in H.pylori eradication rate among 7-day levofloxacin-based triple therapy,10-day levofloxacin-based sequential regimen and conventional sequential therapy
下载PDF
导出
摘要 目的:比较含左氧氟沙星的三联疗法、序贯疗法与传统序贯疗法根治幽门螺杆菌(H.pylori,Hp)的疗效。方法:64例Hp阳性病例,随机分为3组:A组18例予质子泵抑制剂(proton pump inhibitor,PPI)、阿莫西林和左氧氟沙星治疗,疗程7天。B组25例前5天予PPI和阿莫西林,后5天予PPI、克拉霉素和替硝唑。C组21例予含左氧氟沙星的序贯疗法,前5天予PPI、阿莫西林,后5天予PPI、左氧氟沙星及替硝唑。结果:含左氧氟沙星三联疗法Hp根治率为83.33%,标准序贯疗法Hp根治率为84%,含左氧氟沙星序贯疗法Hp根治率为76.19%。结论:含左氧氟沙星的三联疗法、序贯疗法与传统序贯疗法对本地区Hp的根治率没有明显差异。 Objective:To compare the eradication rates of H.pylori among 7-day levofloxacin-based triple therapy,10-day levofloxacin-based sequential regimen and conventional sequential therapy.Methods:The total 64 patients with H.pylori were randomly divided into three groups.Eighteen patients in group A were treated with proton pump inhibitor (PPI),amoxincillin and levofloxacin for 7 days.Tweenty-five patients in group B were treated with PPI and amoxicillin for 5 days,and then with PPI,clarithromycin and tinida zole for another 5 days.Tweenty-one patients in group C were treated with PPI and amoxicillin for 5 days;and then with PPI,levofloxacin and tinidazole for another 5 days.Results:The eradication rate of 7-day levofloxacin-based triple therapy was 83.33%;the eradication rate of conventional sequential therapy was 84%;and that of 10-day levofloxacin-based sequential regimen was 76.19%.Conclusion:There were no significant difference in eradication rate of H.pylori among 7-day levofloxacin-based triple therapy,10-day levofloxacin-based sequential regimen and conventional sequential therapy.
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2010年第10期1439-1441,1444,共4页 Journal of Nanjing Medical University(Natural Sciences)
关键词 左氧氟沙星 序贯疗法 三联疗法 幽门螺杆菌 根治 levofloxacin; sequential therapy; triple therapy; H.pylori; eradication;
  • 相关文献

参考文献17

  • 1胡伏莲.中国幽门螺杆菌耐药研究现状[J].胃肠病学和肝病学杂志,2008,17(7):517-518. 被引量:96
  • 2梁晓,刘文忠,陆红,徐蔚文,萧树东.幽门螺杆菌体外诱导耐药试验和耐药率监测[J].中华消化杂志,2003,23(3):146-149. 被引量:88
  • 3Zaman C,,Osaki T,Hanawa T,et al.Helicobacter pylori represses proton pump expression and inhibits acid secretion in human gastric mucosa. Gut . 2010
  • 4Adamu MA,Weck MN,Pothenbacher D,et al.Incidence and risk factors for the development of chronic atrophic gastritis:Five year follow-up of a population based cohort study. International Journal of Cancer . 2010
  • 5Gong M,Ling SS,Lui SY,et al.Helicobacter pylori gamma-glutamyl-transpeptidase is a pathogenic factor in the development of peptic ulcer disease. Gstroenterology . 2010
  • 6Lin WC,Tsai HF,Kuo SH,et al.Translocation of Helicobacter pylori CagA into Human B lymphocytes,the origin of mucosa-associated lymphoid tissue lymphoma. Cancer Research . 2010
  • 7Craig VJ,Cogliatti SB,Arnold I,et al.B-cell receptor signaling and CD40ligand-independent T cell help cooperate in Helicobacter-induced MALT lymphomagenesis. Leukemia . 2010
  • 8Yin Y,Grabowska AM,Clarke PA,et al.Helicobacter pylori potentiates epithelial:mesenchymal transition in gastric cancer:links to soluble HB-EGF,gastrin and matrix metalloproteinase-7. Gut . 2010
  • 9WHO.IARC monographs on the evaluation of thecarcinogenic risks to humans. . 1994
  • 10Howden CW,Hunt RH.Guidelines for the management of Helicobacter pylori infection.Ad Hoc Committee on Practice Parameters of the American College of Gastroenterology. The American journal of Gastroenterology . 1998

二级参考文献9

  • 1高文,胡伏莲.幽门螺杆菌感染与胃肠道外疾病[J].中国医刊,2007,42(2):22-24. 被引量:30
  • 2成虹,胡伏莲,谢勇,胡品津,王吉耀,吕农华,张建中,张桂英,周曾芬,吴克利,张玲霞,彭孝伟,戴宁,唐国都,姜葵,李岩,侯晓华,白文元,王明春,叶红军,刘玉兰,许乐.中国幽门螺杆菌耐药状况以及耐药对治疗的影响—全国多中心临床研究[J].胃肠病学,2007,12(9):525-530. 被引量:518
  • 3Malfertheiner P, Megraud F, O'Morain C, et al. Current concepts in the management of Helicobacter pylori infection-The maastricht Ⅲ consensus repot [ J ]. Gut, 2007, 56 ( 6 ) :772-781.
  • 4Megraud F. H. pylori antibiotic resistance : prevalence, importance, and advances in testing[ J ]. Gut, 2004, 53 ( 9 ) : 1374-1384.
  • 5Hu FL. Antibiotic resistance status of H. pylori in China. In: 7th China-Korea-Japan Joint Conference on Helicobacter infection:Febury 21- 22, 2008, The Westin Miyako Hotel, Kyoto, Japan 31.
  • 6Satoshi Hoshiya,Kazuhiro Watanabe,Kengo Tokunaga,Akifumi Tanaka,Hidehiko Ninomiya,Masao Shingaki,Takeshi Itoh,Shozo Saito,Hitoshi Ishida,Shin’ichi Takahashi. Relationship between eradication therapy and clarithromycin-resistant Helicobacter pylori in Japan[J] 2000,Journal of Gastroenterology(1):10~14
  • 7F. Szczebara,L. Dhaenens,P. Vincent,M. O. Husson. Evaluation of rapid molecular methods for detection of clarithromycin resistance inHelicobacter pylori[J] 1997,European Journal of Clinical Microbiology & Infectious Diseases(2):162~164
  • 8胡伏莲,胡品津,刘文忠,王继德,吕农华,萧树东,张万岱,成虹,谢勇.第三次全国幽门螺杆菌感染若干问题共识报告[J].胃肠病学,2008,13(1):42-46. 被引量:388
  • 9史彤,刘文忠,萧树东,徐蔚文.上海地区幽门螺杆菌对抗生素耐药率的变迁[J].中华内科杂志,2000,39(8):576-576. 被引量:131

共引文献178

同被引文献84

引证文献8

二级引证文献77

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部